BioNexus Gene Lab Corp Common stock (BGLC) had the highest return between 2017 and 2022 by a US stock, returning 2,780,387.8%.

ASSET	YEARS	% RETURN
BioNexus Gene Lab Corp Common stock (BGLC)	2017-2022	2,780,387.8%
KULR Technology (KULR)	2017-2022	2,399,900%
MDxHealth SA ADR (MDXH)	2017-2022	1,321,900%
Next Technology (NXTT)	2017-2022	1,162,346.87%
Diversified Energy (DEC)	2017-2022	568,050%
Connexa Sports Technologies (YYAI)	2017-2022	467,900%
Avalon GloboCare (ALBT)	2017-2022	466,965.87%
Heart Test Laboratories Inc Common Stock (HSCS)	2017-2022	246,958.82%
GeoVax Labs (GOVX)	2017-2022	230,387.8%
AquaBounty Technologies (AQB)	2017-2022	212,122.22%
Immatics (IMTX)	2017-2022	174,100%
Integra Resources (ITRG)	2017-2022	126,500%
Castellum (CTM)	2017-2022	66,215.79%
Bone Biologics (BBLG)	2017-2022	27,143.24%
Enphase Energy (ENPH)	2017-2022	25,876.47%
Guardforce AI (GFAI)	2017-2022	24,323.08%
GT Biopharma (GTBP)	2017-2022	23,013.04%
INVO Fertility (IVF)	2017-2022	21,711.95%
Applied Digital (APLD)	2017-2022	18,300%
Kaival Brands Innovations (KAVL)	2017-2022	14,858.33%
CIMG (IMG)	2017-2022	9,234.2%
Alarum Technologies (ALAR)	2017-2022	6,979.65%
FitLife Brands, Inc Common Stock (FTLF)	2017-2022	6,618.62%
FingerMotion (FNGR)	2017-2022	5,520%
Zynex (ZYXI)	2017-2022	4,972.94%